Electroacupuncture for chemotherapy-induced hemifacial spasm: a case report.

Researchers reported on a case of a 60-year-old woman with cervical cancer who developed hemifacial spasm (HFS) after receiving chemotherapy. HFS is a condition where the muscles on one side of the face twitch involuntarily and uncontrollably, which can significantly interfere with daily life. In this patient's case, the right side of her face was affected by severe twitching that made everyday activities difficult.

The woman was referred to an acupuncture clinic where she received electroacupuncture (EA) treatment. Electroacupuncture is a form of acupuncture where small electrical currents are passed through the needles to enhance the therapeutic effect. Over the course of 15 treatment sessions, her symptoms improved dramatically. By the end of treatment, the facial twitching had completely stopped.

This case is significant because hemifacial spasm caused by chemotherapy can be challenging to treat with conventional medicine. The complete resolution of symptoms after electroacupuncture suggests this therapy may offer a safe and effective alternative for patients experiencing this distressing side effect of cancer treatment. While this is only one patient's experience and larger studies would be needed to confirm these results, it provides encouraging evidence that acupuncture may help manage chemotherapy-related neurological side effects.

For patients dealing with chemotherapy side effects like facial spasms, this case suggests electroacupuncture might be worth considering as part of a comprehensive treatment plan. Those interested in trying acupuncture for chemotherapy-related symptoms should seek care from a licensed acupuncturist with experience treating cancer patients.

This case report documents electroacupuncture (EA) treatment for chemotherapy-induced hemifacial spasm (HFS) in a 60-year-old female cervical cancer patient. Following chemotherapy, the patient developed severe involuntary right-sided facial muscle twitching that significantly impaired activities of daily living. She received 15 sessions of EA treatment, after which complete resolution of facial muscle twitching was achieved.

Methodology details regarding specific acupoint selection, needle retention time, electrical stimulation parameters, and treatment frequency were not provided in the abstract. The study represents a single-case design (n=1) without control conditions. Effect size cannot be calculated from the available data, though the reported outcome was complete symptom resolution.

Clinical takeaway: EA may represent a viable treatment option for chemotherapy-induced HFS, a condition that can be refractory to conventional interventions. While promising, this single case report provides preliminary evidence only. Practitioners should consider EA as a potential adjunctive therapy for patients presenting with chemotherapy-related neurological complications, particularly when conventional options are limited or poorly tolerated.